IP Library › Granted Patent US 10,947,510
Granted Patent B2
US 10,947,510 · App. 14/079,545 · Granted Mar 16, 2021

Culture medium for epithelial stem cells and organoids comprising the stem cells

Inventors: Toshiro Sato (Tokyo, JP); Johannes C. Clevers (Amsterdam, NL); Meritxell Huch Ortega (Cambridge, GB)
Assignee: Koninklijke Nederlandse Akademie Van Wetenschappen
C12N5/0676C12N5/0677C12N5/0679C12N2501/11C12N2501/117C12N2501/155C12N2501/415C12N2501/70C12N2533/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,947,510
App. No.
14/079,545
Granted
Mar 16, 2021
Kind
B2
Abstract

The invention relates to a method for culturing epithelial stem cells, isolated tissue fragments comprising said epithelial stem cells, or adenoma cells, and culturing the cells or fragments in the presence of a Bone Morphogenetic Protein (BMP) inhibitor, a mitogenic growth factor, and a Wnt agonist when culturing epithelial stem cells and isolated tissue fragments. The invention further relates to a cell culture medium comprising a BMP inhibitor, a mitogenic growth factor, and a Wnt agonist, to the use of said culture medium, and to crypt-villus organoids, gastric organoids and pancreatic organoids that are formed in said culture medium.

Claims (4)

1. An in vitro method for obtaining a gastric organoid, the method comprising culturing gastric epithelial stem cells or isolated tissue fragments comprising said gastric epithelial stem cells in contact with an extracellular matrix for a length of time sufficient to be able to observe formation of a gastric organoid, in a medium comprising Noggin as BMP inhibitor, EGF and FGF10 as mitogenic growth factors, and any one of R-spondin 1 through R-spondin 4 as a Wnt agonist, and further comprising one or more supplements selected from B27, N2, and N-Acetylcystein, and obtaining from the culture medium a gastric organoid.

2. The method of claim 1 , wherein the method further comprises the step of culturing the gastric epithelial stem cells in a second medium.

3. The method according to claim 1 , wherein the gastric epithelial stem cells are gastric epithelial adenoma stem cells.

4. The method according to claim 1 , wherein the culture medium further comprises nicotinamide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2015
From: SATO, TOSHIRO; CLEVERS, JOHANNES CAROLUS; HUCH ORTEGA, MERITXELL
To: KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN
Reel/Frame 036420/0677 →
Priority Claims (2)
EP 09151970 · Feb 3, 2009 · regional
EP 09171831 · Sep 30, 2009 · regional
Continuity (3)
Continuation 13147163
Provisional Application 61149622 · Feb 3, 2009
Related Publication 20140256037A1 · Sep 11, 2014
Cited By (2)
US 12,517,112 US 12,649,903